Therefore, the impact of IKKɛ loss in a cell is dual: impaired MEK1 and ERK1/2 phosphorylations and dysregulated transcription of MAPK feedback inhibitors, both of which render tumor cells unable to activate ERK1/2/MAPK pathway. The gene discussed is MAPK3; the disease is neoplasm.